Information Library

Results for: Product Development & Commercialization - Market Access

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Consulting – Breakthrough Thinking Built on Experience

    Brochure — November 23, 2010
    Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today.

  • Oncology Drug Development and Value-Based Medicine

    White Paper — November 5, 2010
    This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices.

  • Advancing Oncology Care Through Innovative Treatment Approaches

    White Paper — September 22, 2010
    In this new white paper, Quintiles’ oncology experts Harish Dave and Eric Groves summarize the new findings and promising results presented at the June ASCO 2010 meeting.

  • Executive Vision Forum 2010: Convergence of Stakeholders

    Presentation — July 9, 2010
    A Holistic Approach to Patient Outcomes - Brian Sweet, CPO, WellPoint. Presentation about the convergence of stakeholders.

  • Executive Vision Forum 2010: Clinical and Commercial Convergence

    Presentation — July 8, 2010
    Pasquale Cetera, VP Portfolio Management, Merck, presentation about the convergence of Clinical and Commercial.

  • Bridging Cultures

    Case Study — May 9, 2010
    Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise.

  • PharmAsia News Article Reprint

    Media Coverage — March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

  • Rewarding Innovation and Value

    White Paper — October 6, 2009
    The impact of comparative effectiveness research on the future of drug development.

  • Orphan Drugs in the U.S.

    Presentation — June 24, 2009
    Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009(International Society for Pharmacoeconomics and Outcomes Research) on “Orphan Drugs' Market Access in the U.S.”

  • Poised for success

    Presentation — June 16, 2009
    Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility

Page 1 of 2 (15 results)

Subscribe to Email Based on Your Interests

Set preferences